🔗 Share this article

This year's Nobel Prize in Physiology or Medicine was awarded for transformative discoveries that illuminate how the body's defense network attacks harmful pathogens while protecting the healthy tissues.

Three esteemed scientists—from Japan Prof. Sakaguchi and American experts Mary Brunkow and Fred Ramsdell—share this accolade.

Their research uncovered unique "security guards" within the immune system that eliminate rogue immune cells that could attacking the body.

The findings are now paving the way for new treatments for immune disorders and cancer.

These laureates will share a prize fund valued at 11 million Swedish kronor.

Crucial Discoveries

"The work has been essential for comprehending how the immune system operates and why we do not all develop severe self-attack conditions," commented the chair of the award panel.

This trio's studies explain a core question: How does the defense system defend us from countless infections while leaving our healthy cells intact?

The body's protection system employs immune cells that scan for indicators of infection, including pathogens and germs it has never encountered.

These cells utilize sensors—known as recognition units—that are produced by chance in countless variations.

This provides the immune system the ability to combat a wide array of threats, but the randomness of the process unavoidably produces immune cells that may attack the host.

Security Guards of the Immune System

Researchers previously understood that a portion of these harmful white blood cells were destroyed in the thymus—where white blood cells develop.

This year's Nobel Prize recognizes the discovery of regulatory T-cells—described as the immune system's "peacekeepers"—which travel through the body to disarm any immune cells that assault the healthy cells.

We know that this mechanism malfunctions in self-attack conditions such as juvenile diabetes, MS, and rheumatoid arthritis.

A prize committee stated, "The findings have laid the foundation for a new field of investigation and spurred the development of innovative treatments, for example for cancer and autoimmune diseases."

Regarding malignancies, T-regs prevent the body from attacking the tumor, so research are aimed at reducing their numbers.

For autoimmune diseases, experiments are testing increasing regulatory T-cells so the organism is not being harmed. A comparable method could also be useful in minimizing the chances of transplanted organ failure.

Innovative Studies

Prof Sakaguchi, from Osaka University, performed tests on mice that had their thymus removed, leading to autoimmune disease.

He demonstrated that introducing defense cells from healthy mice could stop the disease—implying there was a mechanism for blocking defenders from harming the host.

Mary Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Dr. Ramsdell, now at a biotech firm in San Francisco, were studying an genetic autoimmune disease in rodents and humans that led to the identification of a gene critical for how regulatory T-cells function.

"Their groundbreaking research has revealed how the body's defenses is kept in check by regulatory T cells, stopping it from mistakenly targeting the healthy cells," said a leading biological science expert.

"The work is a remarkable example of how fundamental physiological research can have broad consequences for human health."